If you’re keen to stay updated on the latest mesothelioma legal news, get ready to dive into the world of medical business with a comparison of Inhibrx (NASDAQ: INBX) and Sorrento Therapeutics (OTCMKTS: SRNEQ). Both of these firms are currently making waves in the small-cap medical sector, but which one comes out on top?
To determine the more promising business, we’ll delve deep into the strength of their institutional ownership. This factor is incredibly crucial, as it highlights the level of confidence that major financial institutions have in the companies. It’s a tell-tale sign of the potential growth and stability that these medical companies can offer.
So, whether you’re an investor, a medical professional, or simply a news enthusiast, stay tuned as we throw light on the comparative strength of Inhibrx and Sorrento Therapeutics!
Original source: ETF Daily News
Leave a Reply